CRM

Salesforce, Inc.

67
Fundamentals67/ 100
Valuation74/ 100
Upside potential46/ 100
Risk potential26/ 100

CRM has the edge over CRWV overall, supported by stronger valuation and stronger fundamentals.

CRWV

CoreWeave, Inc. Class A Common Stock

52
Fundamentals43/ 100
Valuation50/ 100
Upside potential65/ 100
Risk potential42/ 100

CRWV offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.

CRM Fundamentals

MetricStatus
Healthy
Healthy
Strong
Stable

CRM's revenue, profitability and cash flow are currently healthy, and its balance sheet is stable.

CRWV Fundamentals

MetricStatus
Strong
Under pressure
Weak
Strong

CRWV's revenue and balance sheet are currently strong, but its profitability and cash flow are under pressure.

CRM PE Valuation

CHEAPFAIREXPENSIVE267x533x800x1067x
CHEAPFAIREXPENSIVE267x533x800x1067x
LevelPEPriceVs current
Current20x$218—
Cheap36x$393+80%
Fair70x$766+252%
Expensive293x$3,206+1374%

Historical ranges are pointers, not guarantees.

CRM's PE is in its cheap range at 20x, but its recent earnings include one-off gains.

CRWV PE Valuation

CRWV has no meaningful PE right now: it lost money over the past year.

CRM Forward outlook

There aren't enough analyst estimates for CRM to show an outlook.

CRWV Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Moderate
Low

Analysts expect CRWV's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

CRM Risk to reward

ScenarioChangePrice
Upside+22%$266.42
Downside-26%$160.73

Calculated from the latest close: $217.57 on Nov 12.

CRM trails CRWV on modeled risk to reward, with less potential upside relative to its potential downside.

CRWV Risk to reward

ScenarioChangePrice
Upside+79%$101.48
Downside-42%$32.77

Calculated from the latest close: $56.60 on Nov 12.

CRWV has a better modeled risk to reward balance than CRM, with more potential upside relative to its potential downside.

CRM Earnings Per Share

Q4 2023: $2.63Q1 2024: $4.20Q2 2024: $5.56Q3 2024: $5.75Q4 2024: $6.08Q1 2025: $6.36Q2 2025: $6.39Q3 2025: $6.88Q4 2025: $7.49Q1 2026: $7.80Q2 2026: $8.63Q3 2026: $10.96
Q4 2023: $2.63Q1 2024: $4.20Q2 2024: $5.56Q3 2024: $5.75Q4 2024: $6.08Q1 2025: $6.36Q2 2025: $6.39Q3 2025: $6.88Q4 2025: $7.49Q1 2026: $7.80Q2 2026: $8.63Q3 2026: $10.96
QuarterTTM EPSYoY
Q3 2026$10.96+59%
Q2 2026$8.63+35%
Q1 2026$7.80+23%
Q4 2025$7.49+23%
Q3 2025$6.88+20%
Q2 2025$6.39+15%
Q1 2025$6.36+51%
Q4 2024$6.08+131%

CRM has the edge over CRWV on earnings quality, reporting a profit while its opponent remains loss making.

CRWV Earnings Per Share

Q3 2024: $-2.42Q4 2024: $-2.17Q1 2025: $-3.34Q2 2025: $-3.10Q3 2025: $-2.48Q4 2025: $-2.81Q1 2026: $-2.72Q2 2026: $-3.26Q3 2026: $-4.31
Q3 2024: $-2.42Q4 2024: $-2.17Q1 2025: $-3.34Q2 2025: $-3.10Q3 2025: $-2.48Q4 2025: $-2.81Q1 2026: $-2.72Q2 2026: $-3.26Q3 2026: $-4.31
QuarterTTM EPSYoY
Q3 2026-$4.31-$1.83
Q2 2026-$3.26-$0.16
Q1 2026-$2.72+$0.62
Q4 2025-$2.81-$0.64
Q3 2025-$2.48-$0.06

CRWV lost $4.31 per share over the past year, a bigger loss than the year before.

CRM Quarterly Revenue

Q4 2023: $8.7BQ1 2024: $9.3BQ2 2024: $9.1BQ3 2024: $9.3BQ4 2024: $9.4BQ1 2025: $10BQ2 2025: $9.8BQ3 2025: $10.2BQ4 2025: $10.3BQ1 2026: $11.2BQ2 2026: $11.1BQ3 2026: $11.3B
Q4 2023: $8.7BQ1 2024: $9.3BQ2 2024: $9.1BQ3 2024: $9.3BQ4 2024: $9.4BQ1 2025: $10BQ2 2025: $9.8BQ3 2025: $10.2BQ4 2025: $10.3BQ1 2026: $11.2BQ2 2026: $11.1BQ3 2026: $11.3B
QuarterRevenueYoY
Q3 2026$11.3B+11%
Q2 2026$11.1B+13%
Q1 2026$11.2B+12%
Q4 2025$10.3B+8.6%
Q3 2025$10.2B+9.8%
Q2 2025$9.8B+7.6%
Q1 2025$10B+7.6%
Q4 2024$9.4B+8.3%

CRM's revenue has grown year over year every quarter since late 2020: $11.3B last quarter, up 11% from the same quarter a year ago.

CRWV Quarterly Revenue

Q4 2023: $116MQ1 2024: $189MQ2 2024: $395MQ3 2024: $584MQ4 2024: $747MQ1 2025: $982MQ2 2025: $1.2BQ3 2025: $1.4BQ4 2025: $1.6BQ1 2026: $2.1BQ2 2026: $2.6BQ3 2026: $3.7B
Q4 2023: $116MQ1 2024: $189MQ2 2024: $395MQ3 2024: $584MQ4 2024: $747MQ1 2025: $982MQ2 2025: $1.2BQ3 2025: $1.4BQ4 2025: $1.6BQ1 2026: $2.1BQ2 2026: $2.6BQ3 2026: $3.7B
QuarterRevenueYoY
Q3 2026$3.7B+168%
Q2 2026$2.6B+112%
Q1 2026$2.1B+112%
Q4 2025$1.6B+110%
Q3 2025$1.4B+134%
Q2 2025$1.2B+207%
Q1 2025$981.6M+420%
Q4 2024$747.4M+544%

CRWV has the edge over CRM on sales, with stronger typical year-over-year growth.

CRM Free Cash Flow

Q4 2023: $1.4BQ1 2024: $3.3BQ2 2024: $6.1BQ3 2024: $755MQ4 2024: $1.8BQ1 2025: $3.8BQ2 2025: $6.3BQ3 2025: $605MQ4 2025: $2.2BQ1 2026: $5.3BQ2 2026: $6.6BQ3 2026: $1.1B
Q4 2023: $1.4BQ1 2024: $3.3BQ2 2024: $6.1BQ3 2024: $755MQ4 2024: $1.8BQ1 2025: $3.8BQ2 2025: $6.3BQ3 2025: $605MQ4 2025: $2.2BQ1 2026: $5.3BQ2 2026: $6.6BQ3 2026: $1.1B
QuarterFree cash flowYoY
Q3 2026$1.1B+81%
Q2 2026$6.6B+4.1%
Q1 2026$5.3B+39%
Q4 2025$2.2B+22%
Q3 2025$605M-20%
Q2 2025$6.3B+3.5%
Q1 2025$3.8B+17%
Q4 2024$1.8B+30%

CRM has the edge over CRWV on cash generation, producing positive trailing cash flow while its opponent burns cash.

CRWV Free Cash Flow

Q4 2023: −$1.1BQ1 2024: $297MQ2 2024: −$2.4BQ3 2024: −$574MQ4 2024: −$3.3BQ1 2025: −$1.3BQ2 2025: −$2.7BQ3 2025: −$700MQ4 2025: −$2.5BQ1 2026: −$4.7BQ2 2026: −$5.7BQ3 2026: −$7.5B
Q4 2023: −$1.1BQ1 2024: $297MQ2 2024: −$2.4BQ3 2024: −$574MQ4 2024: −$3.3BQ1 2025: −$1.3BQ2 2025: −$2.7BQ3 2025: −$700MQ4 2025: −$2.5BQ1 2026: −$4.7BQ2 2026: −$5.7BQ3 2026: −$7.5B
QuarterFree cash flowYoY
Q3 2026-$7.5B-$6.8B
Q2 2026-$5.7B-$3B
Q1 2026-$4.7B-$3.4B
Q4 2025-$2.5B+$810.3M
Q3 2025-$699.8M-$125.8M
Q2 2025-$2.7B-$339.3M
Q1 2025-$1.3B-553%
Q4 2024-$3.3B-$2.2B

CRWV has burned cash in almost every quarter: −$20.4B over the past year, against −$8.1B the year before.

CRM Total Shares

Q4 2023: 981MQ1 2024: 984MQ2 2024: 985MQ3 2024: 973MQ4 2024: 965MQ1 2025: 974MQ2 2025: 970MQ3 2025: 962MQ4 2025: 952MQ1 2026: 956MQ2 2026: 871MQ3 2026: 821M
Q4 2023: 981MQ1 2024: 984MQ2 2024: 985MQ3 2024: 973MQ4 2024: 965MQ1 2025: 974MQ2 2025: 970MQ3 2025: 962MQ4 2025: 952MQ1 2026: 956MQ2 2026: 871MQ3 2026: 821M
PeriodChange %Net change
Quarterly-5.7%-50M shares
1 year-15%-141M shares
3 years-17%-165M shares
5 years-14%-129M shares
Available history-6.6%-58M shares

CRM has the edge over CRWV on shareholder dilution, with a more favorable share count trend.

CRWV Total Shares

Q4 2023: 404MQ1 2024: 404MQ2 2024: 404MQ3 2024: 214MQ4 2024: 239MQ1 2025: 249MQ2 2025: 487MQ3 2025: 498MQ4 2025: 436MQ1 2026: 527MQ2 2026: 551MQ3 2026: 559M
Q4 2023: 404MQ1 2024: 404MQ2 2024: 404MQ3 2024: 214MQ4 2024: 239MQ1 2025: 249MQ2 2025: 487MQ3 2025: 498MQ4 2025: 436MQ1 2026: 527MQ2 2026: 551MQ3 2026: 559M
PeriodChange %Net change
Quarterly+1.5%+8M shares
1 year+12%+61.1M shares

CRWV has 559M diluted shares, up 12% from a year ago.

CRM Net Leverage

Q4 2023: 0.4xQ1 2024: 0.1xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.0xQ1 2025: -0.0xQ2 2025: -0.2xQ3 2025: -0.2xQ4 2025: -0.1xQ1 2026: 0.6xQ2 2026: 2.4xQ3 2026: 2.5x
Q4 2023: 0.4xQ1 2024: 0.1xQ2 2024: -0.1xQ3 2024: 0.1xQ4 2024: 0.0xQ1 2025: -0.0xQ2 2025: -0.2xQ3 2025: -0.2xQ4 2025: -0.1xQ1 2026: 0.6xQ2 2026: 2.4xQ3 2026: 2.5x
QuarterNet LeverageStatus
Q3 20262.5xModerate
Q2 20262.4xModerate
Q1 20260.6xVery low
Q4 2025-0.1xNet Cash
Q3 2025-0.2xNet Cash
Q2 2025-0.2xNet Cash
Q1 2025-0.0xNet Cash
Q4 20240.0xVery low

CRM's net debt is about 2.5 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.

CRWV Net Leverage

Q4 2024: 19.3xQ1 2025: 8.4xQ2 2025: 6.5xQ3 2025: 5.6xQ4 2025: 7.6xQ1 2026: 7.6xQ2 2026: -1.5xQ3 2026: -0.8x
Q4 2024: 19.3xQ1 2025: 8.4xQ2 2025: 6.5xQ3 2025: 5.6xQ4 2025: 7.6xQ1 2026: 7.6xQ2 2026: -1.5xQ3 2026: -0.8x
QuarterNet LeverageStatus
Q3 2026-0.8xNet Cash
Q2 2026-1.5xNet Cash
Q1 20267.6xHigh
Q4 20257.6xHigh
Q3 20255.6xHigh
Q2 20256.5xHigh
Q1 20258.4xHigh
Q4 202419.3xHigh

CRWV has the edge over CRM on leverage, with a lower net debt burden relative to earnings.

CRM Weekly Momentum

MetricValueStatus
RSI50.7Neutral
Stochastic44.2Neutral

CRM's weekly RSI is 51 (neutral) and its Stochastic is 44 (neutral).

CRWV Weekly Momentum

MetricValueStatus
RSI39.7Neutral
Stochastic11.3Oversold

CRWV's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).

CRM PE vs Technology Sector

MetricCRMSector medianRelative
PE20x28x29% below
PE %23533 pts below

CRM is trading at 20x earnings, a 29% discount to the Technology sector's median of 28x, though its recent earnings include one-off gains.

CRWV PE vs Technology Sector

CRWV has no meaningful PE right now: it lost money over the past year.

CRM Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$230.95.8% below
20 week MA$214.71.3% above
50 week MA$206.85.2% above
100 week MA$239.79.2% below
200 week MA$242.010% below

CRM has stronger trend alignment. CRM is above 2 of 5 weekly averages versus CRWV above 0 of 3.

CRWV Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$66.615% below
20 week MA$77.427% below
50 week MA$87.435% below

CRWV is in a downtrend: it's below all three of its weekly moving averages, and 35% below its 50-week average.

CRM Yearly ROI

YearStart priceEnd priceROI
2020$165.0$225.8+37%
2021$225.8$253.1+12%
2022$253.1$129.4-49%
2023$129.4$263.1+103%
2024$263.1$338.5+29%
2025$338.5$266.1-21%
2026 YTD$266.1$217.6-18%

CRM has the edge over CRWV on returns for 2026, with the stronger performance.

CRWV Yearly ROI

YearStart priceEnd priceROI
2025$40.0$76.4+91%
2026 YTD$76.4$56.6-26%

CRWV has finished every year since 2025 higher, and it's down 26% so far in 2026.

Give your agent the market.

Get API key